
Galaxy Medicare Limited IPO
Galaxy Medicare Limited IPO is a SME book building IPO. Price band is ₹51 to ₹54 per share. Minimum investment is ₹2.16 L. Lot size is 2000 shares. Open from 10 Sept 2025 to 12 Sept 2025. Allotment on 15 Sept 2025. Listing on 17 Sept 2025 at NSE. Managed by Affinity Global Capital Market Pvt.Ltd. Registrar: Cameo Corporate Services Limited. Key details for GMP, subscription, price, allotment, and listing in one place.
Galaxy Medicare Limited IPO overview
Galaxy Medicare Limited IPO Key figures
Price band, lot, minimum application, and issue window at a glance.
Galaxy Medicare Limited IPO important dates
Galaxy Medicare Limited IPO lot size
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 4,000 | ₹2,16,000 |
| S-HNI (Min) | 3 | 6,000 | ₹3,24,000 |
| S-HNI (UPI) | 4 | 8,000 | ₹4,32,000 |
| S-HNI (Max) | 9 | 18,000 | ₹9,72,000 |
| B-HNI (Min) | 10 | 20,000 | ₹10,80,000 |
About Galaxy Medicare Limited IPO
From the company / RHP narrative.
The company manufactures these products using premium grade raw material that is procured from the authentic vendors of the market.
The company specializes in various products, including surgical dressings, plaster of Paris bandages, adhesive tapes, compression bandages, and wound care solutions.
Their offerings meet diverse medical needs, including gauze products and orthopedic items.
The company's business includes the following:-
Manufacturing and branding for flagship brands: POP BAND, POP CAST, G CAST, GYPSOSOFT, GYPSOPLAST, CARETAPE, GYPSOCREPE, CARECREPE, CAREPORE, GYPSONET, GYPSOCHLOR, FIXCAN ETC.;
OEMs source components, design, manufacture, and test quality according to brand owners' specifications under Principal-to-Principal basis;
Institutional sales via government tenders on GEM Portal;
Exporting its products internationally and trading surgical devices dressings.
The company has 27 registered trademarks in India, serving domestic and international markets.
The company's products are accepted by the medical community and supplied throughout India to government health departments, corporate hospitals, and private entities.
The company complies with ISO 9001:2015 and ISO 13485:2016 certifications, ensuring that its products meet the rigorous demands of healthcare institutions.
As of March 2025, the company has 190 employees in various departments.
Competitive Strength:
Experienced Leadership and Skilled Management Team.
Established reputation and customer relationships.
Focus on consistently meeting quality standards.
Well Established Manufacturing Facility with Wide Range of Products.
In-house Quality Assurance (QA) / Quality Control (QC) and Research & Development for quality control.
International market Presence.
Objective of the issue
How the issuer plans to use IPO proceeds.
Funding the working capital requirements
General Corporate Purposes
To meet the offer related expenses
Ratings & reviews
Community ratings and reviews — not financial advice.
No ratings yet — be the first to share your experience.
Follow the latest IPO & unlisted research on iOS and Android.
Documents & links
Prospectus, draft filings, and company site open in a new tab.
Registrar
Details about the registrar of the issue.
Issue details
Key details about the issue, including the face value, lot size, and minimum investment.
Related articles
Research posts and updates that reference this company or theme.
Follow the latest IPO & unlisted research on iOS and Android.